Clinical trials
Attention Deficit Disorder with Hyperactivity trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 2 |
| 2008 | 5 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Unknown status | 4 |
| Recruiting | 2 |
| Terminated | 2 |
| Withdrawn | 1 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 8 |
| Shire | 5 |
| Radboud University Medical Center | 4 |
| UMC Utrecht | 3 |
| Amsterdam UMC, location VUmc | 2 |
| Erasmus Medical Center | 2 |
| Janssen-Cilag International NV | 2 |
| Universiteit Leiden | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Accare | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Attention Deficit Disorder with Hyperactivity | 44 |
| Cognitive Dysfunction | 2 |
| Memory Disorders | 2 |
| Anxiety Disorders | 1 |
| Autistic Disorder | 1 |
| Brain Injuries | 1 |
| COVID-19 | 1 |
| Cognition Disorders | 1 |
| Dyslexia | 1 |
| Marijuana Abuse | 1 |
Trials
Showing 26 to 44 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.